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Abstract
Iron is essential for organisms. It is mainly utilized in mitochondria for biosynthesis of iron-sulfur clusters, hemes and other
cofactors. Mitoferrin 1 and mitoferrin 2, two homologues proteins belonging to the mitochondrial solute carrier family, are
required for iron delivery into mitochondria. Mitoferrin 1 is highly expressed in developing erythrocytes which consume a
large amount of iron during hemoglobinization. Mitoferrin 2 is ubiquitously expressed, whose functions are less known.
Zebrafish with mitoferrin 1 mutation show profound hypochromic anaemia and erythroid maturation arrests, and yeast with
defects in MRS3/4, the counterparts of mitoferrin 1/2, has low mitochondrial iron levels and grows poorly by iron depletion.
Mitoferrin 1 expression is up-regulated in yeast and mouse models of Fiedreich’s ataxia disease and in human cell culture
models of Parkinson disease, suggesting its involvement in the pathogenesis of diseases with mitochondrial iron
accumulation. In this study we found that reduced mitoferrin levels in C. elegans by RNAi treatment causes pleiotropic
phenotypes such as small body size, reduced fecundity, slow movement and increased sensitivity to paraquat. Despite these
abnormities, lifespan was increased by 50% to 80% in N2 wild type strain, and in further studies using the RNAi sensitive
strain eri-1, more than doubled lifespan was observed. The pathways or mechanisms responsible for the lifespan extension
and other phenotypes of mitoferrin RNAi worms are worth further study, which may contribute to our understanding of
aging mechanisms and the pathogenesis of iron disorder related diseases.
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Introduction
Iron is essential for organisms. It is mainly utilized in
mitochondria for biosynthesis of hemes, iron-sulfur clusters (Fe-S
clusters) and other cofactors [1–3]. Hemes are found in
hemoglobin, myoglobin, and cytochromes [3]. Fe-S clusters are
cofactors of many proteins involved in respiration, transcription,
amino acid synthesis and other processes [1,4,5]. However, too
much iron is detrimental, and iron accumulation in mitochondria
is associated with many human genetic disorders, e.g., Fiedreich’s
ataxia (FRDA), Sideroblastic anemias (SA), ISCU Myopathy,
Alzheimer’s Disease (AD), Parkinson’s disease (PD) and Multiple
Sclerosis (MS) [6–12]. Aging is a risk factor for these diseases, most
of which occur at a high rate of frequency at old age. Iron
accumulation is also accompanied with aging [13,14]. The content
of iron is increased in organs of aged animals and during aging our
body accumulates a brown material in the tissues known as
lipofuscin (age-pigment), which is a mass of fat and iron [15–17].
The mechanisms regulating mitochondrial iron homeostasis are
largely unknown. Iron delivery into mitochondria is facilitated by
mitoferrin 1 and mitoferrin 2, two homologous proteins of the
mitochondrial solute carrier family [18,19]. Down-regulation of
mitoferrin 1 and/or mitoferrin 2 levels by RNAi treatment result
in decreased mitochondrial iron content and reduced iron-sulfur
cluster and heme synthesis [19]. Mitoferrin 1 is highly expressed in
haematopoietic tissues and is essential for erythroid iron
assimilation. Zebrafish with mitoferrin 1 mutation shows profound
hypochromic anaemia and erythroid maturation arrests [19,20].
Targeted deletion of mouse mitoferrin 1 leads to anemia and
protoporphyria [21]. Ferrochelatase, the terminal heme synthesis
enzyme catalyzing the insertion of iron into protoporphyrin IX
during heme production, and abcb10, a mitochondrial inner
membrane ATP-binding cassette transporter induced during
erythropoiesis in hematopoietic tissues, can form complex with
mitoferrin 1 during mouse erythroleukemia cell differentiation
[22,23]. Mitoferrin 2 is widely expressed in most tissues and
possibly functions to maintain the base line levels of mitochondrial
iron in non-erythroid cells [19,20]. Less is known about mitoferrin
2 due to a lack of gene knockout models. Invertebrates such as
Drosophila melanogaster, Caenorhabditis elegans, sea urchin, bee, wasp,
mosquito, and flour beetle have a single mitoferrin protein which
shows similarity to vertebrate mitoferrin 2 due to lack of
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Drosophila [25]. Yeast with defects in MRS3/4, counterparts of
mitoferrin 1/2, grows poorly under low iron conditions [26–28].
Cross-species gene complement experiments showed that mitoferrin
genes are conserved in evolution. For example, defects of yeast
MRS3/4 mutant can be rescued by zebrafish mfrns and murine
mfrn1 can complement zebrafish mutant [19,20].
Mitoferrin is also involved in pathogenesis of human genetics
diseases. The expression of mitoferrin is up-regulated in yeast and
mouse models of Fiedreich’s ataxia (FRDA) and in human cell
culture models of Parkinson disease [29,30], which may contribute
to mitochondrial iron accumulation and cytosolic iron deficiency,
primary symptoms of those diseases.
The nematode Caenorhabditis elegans is an animal model widely
used for studies of subjects including development, cell death, aging
and diseases [31–33]. It is easy to maintain in laboratory, it is
transparent and has a lifecycle of only 3 days at 20uC. Many
experimental technologies such as RNA interference (RNAi) and
genetic analysis are extensively used in C. elegans [34,35]. In this
study we found that C. elegans feeding on E.coli HT115 (DE3) strain
containing RNAi construct targeting W02B12.9 (worm mitoferrin)
showed pleiotropic phenotypes such as small body size, reduced
fecundity, slowed movement and increased sensitivity to paraquat.
Despite these abnormities, lifespan was increased by 50% to 80% in
N2 wild type strain, and in further studies using the RNAi sensitive
straineri-1,morethandoubledlifespanwas observed.Althoughmfn-
1 RNAi worms were smaller and produced fewer progenies than
control, their growth and reproduction periods seem normal,
neither prolonged nor shortened. Further investigation into the
pathwaysormechanismsresponsiblefortheincreasedlongevityand
other phenotypes may contribute to our understanding of aging and
may have implications in treatment of diseases associated with
mitochondrial iron accumulation.
Materials and Methods
Strains and worm culture
The C. elegans strains used in the experiments are wild type
Bristol N2 and RNAi hypersensitive strain GR1373 eri-1(mg366)
IV, supplied by the Caenorhabditis Genetics Center (University of
Minnesota, MN). Worms were cultured and maintained on NGM
plates as described [36]. Unless stated otherwise, worms were
cultured at 20uC.
RNAi vector construction
Fragment used for RNAi constructs was obtained by polymer-
ase chain reaction (PCR) from C. elegans genomic DNA that was
isolated using standard methods [37]. The fragment obtained
corresponds to a segment of the second exon of W02B12.9.
Sequence specificity of the fragment for RNAi was confirmed by
blast searches against worm database. Primers used for PCR were:
Forward primer: 59-GTTAGATCTCTGAAAC-
GAAATGTCCA-39 (Bgl II enzyme site was underlined);
Reverse primer: 59-TAAGGTACCAAGTCCTCCCG-
CAA-39 (Kpn I enzyme site was underlined).
PCR product was cloned into l4440 vector. Another RNAi
vector targeting a different region of W02B12.9 was constructed
by similar method, except that cDNA was used as the template.
Primers used for PCR were:
Forward primer: 59-CAGAGATCTAGGACTTGCC-
GGCGGATTGG-39 (Bgl II enzyme site was underlined);
Reverse primer: 59-CGCAAGCTTTCAACTCGAAT-
GACCTCCT-39 (Hind III enzyme site was underlined).
E. coli RNase III-deficient strain HT115 (DE3) transformed by
the recombinant RNAi vector was selected on agar plates
containing 100 mg/ml ampicillin and 12.5 mg/ml tetracyclin.
The authenticity of the recombinant RNAi constructs was
confirmed by sequencing.
Bacterially mediated RNAi
Single clone of HT115 (DE3) bacteria transformed by
W02B12.9 RNAi construct was inoculated in LB medium
containing 50 mg/ml ampicillin and let grow overnight at 37uC
and 250 rpm. Over night culture was diluted 1:100 in 3 ml fresh
LB medium containing 50 mg/ml ampicillin and allowed to grow
for 8–10 hours. Then the bacteria was seeded onto NGM plates
containing 50 mg/ml ampicillin and 1 mM IPTG and was induced
over night at room temperature. L4 staged hermaphrodites were
transferred onto the bacterial lawn and let grow at 20uC for RNAi
to take effect. Worms feeding on bacteria transformed by empty
vector l4440 were used as control. The procedures were essentially
described [38].
Locomotive rate assay
Several L4 staged hermaphrodites were transferred onto
W02B12.9 RNAi or l4440 RNAi plates respectively and let grow
for three or four days for RNAi to take effect. One-day old F1
adults (24 hours after L4 stage was defined as one-day old and L4
stage was defined as day 0) were transferred onto fresh plates
(without bacteria) for locomotive rate assay. Locomotive activity
was determined by counting the number of front body bends in
20 seconds using an inverted microscope. When the anterior body
region of the worm just behind the pharynx reached a maximum
bend in the opposite direction from the last bend, the body bend
count was advanced by one. The body bend values of five animals
on each plate were manually counted and averaged in every
paired experiment.
Body length measurement
Several L4 staged hermaphrodites were transferred onto
W02B12.9 or l4440 RNAi plates respectively and let grow for
three or four days for RNAi to take effect. Five to seven young
adult hermaphrodites of F1 generation were transferred onto fresh
prepared RNAi plate and were removed two hours later, about
dozens of synchronized eggs should be laid during this period. The
F2 generation on the plate were photographed every twenty four
hours until growth stopped using a Nikon Eclipse E600
microscope equipped with a Nikon digital camera. A ruler was
also photographed at the same magnification for determination of
body length.
Brood size assay
After one generation’s treatment by W02B12.9 RNAi or control
RNAi, five to seven L4 staged F1 hermaphrodites were placed onto
corresponding RNAi plates. The same animals were transferred to
fresh plate every 24 hours until reproduction ceased. The number
of eggs and the number of hatched worms were counted everyday
after L4 stage for brood size determination.
Microscopy and imaging
Images were captured by a Nikon digital camera attached to a
Nikon Eclipse E600 microscope. Images used for body length
measurement were directly captured from worms on the plates.
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onto a piece of 2% agar and anaesthetized with 1% levamisole in
M9 solution, then were examined under the microscope and
photographed [39].
Life span assay
Life span was defined as time period between L4 stage and the
day worm was dead [40]. After three or four days’ feeding on
bacteria containing W02B12.9 RNAi or l4440 RNAi vectors,
more than sixty L4 staged hermaphrodites of F1 generation were
transferred onto fresh prepared RNAi plate respectively. The same
animals were transferred everyday onto fresh plates during
reproductive period to avoid interference of offspring, and every
two or three days afterward until none were alive. Worms that do
not respond to gentle nose touch with a platinum wire were
considered dead. Worms that crawled off the plate or died from
hatched embryos in the uterus were scored as censored data. The
Graphpad Prism software was used to compare survival curves for
statistical analysis.
Paraquat sensitivity test
After one generation’s RNAi treatment, around thirty three-day
old F1 adults were put into 96-well plates with M9 solution
containing 100 mM paraquat (1, 19-dimethyl-4,49-bipyridinium
dichloride, Sigma-Aldrich). Dead worms were counted every
5 hours up to the 25-hour time point. Worms that do not respond
to gentle nose touch with a platinum wire were considered dead.
Quantitative real-time PCR
After one generation’s RNAi treatment, ten L4 staged F1
hermaphrodites were transferred onto corresponding RNAi plates.
Four days later, mix-staged worms on the plate were washed into a
1.5 ml tube with ddH2O and were centrifuged twice at low speed
(200 rpm) to remove bacteria. Total RNA from about 10 to 15 ml
worm pellet was isolated using trizol reagent (Invitrogen). Intact
RNA was checked by running a 2% agrose electrophoresis and
was quantified spectrometrically (Beckman Coulter DU-800).
Obtained RNA was converted to cDNA using the PrimeScript
RT reagent kit (Takara). 1 ml of the resulting cDNA was used for
quantitative real-time PCR using the SYBR Premix EX Taq
TM
(Takara) and the ABI PRISM 7700HT Real-Time PCR System
(Applied Biosystems). The qRT-PCR conditions were: 95uC for
30 s, followed by a 40-cycles of 5 s at 95uC and 30 s at 60uC.
Specificity of the amplified product was ensured by melting curve
analysis. W02B12.9 mRNA levels in worms are normalized to the
internal control act-1. Premiers for act-1 are:
Forward primer: 59-CCGCTCTTGCCCCATCAAC-
39;
Reverse primer: 59-AAGCACTTGCGGTGAAC-
GATG-39.
Primers for W02B12.9 are:
Forward primer: 59-GGCGAATTTTCTTG-
CAGGCT-39;
Reverse primer: 59-TCAACTCGAATGACCTCCTT-
39.
Primers were designed to span across one intron to make sure
that products can only be amplified from cDNA, not genomic
DNA, in order to avoid interference of the latter. The qRT-PCR
experiments were repeated three times using independent RNA
preparations.
Statistical analysis
Statistical analyses for body length, brood size, locomotive rate
and qRT-PCR were performed by Student’s t test. Life span and
paraquat sensitivity statistics were analyzed using Kaplan-Meier
survival method followed by log-rank test. The Graphpad prism 5
software was used for analysis.
Internet resources and software
Gene and protein sequences were obtained and submitted to
blast searches at ncbi (http://www.ncbi.nlm.nih.gov/) and worm
base (www.wormbase.org). Primers were designed using the
Primer 5 software and sequence alignments were created using
BioEdit v 7.0.9. Predicted transmembrane regions of proteins were
obtained from Uniprot database (http://www.uniprot.org/).
Results
C. elegans W02B12.9 is the only homologue of vertebrate
mitoferrin 1/2 and yeast MRS3/4
Invertebrates were reported to have one mitoferrin [24,25]. We
performed blast searches against Worm protein database using
mitoferrin proteins of Saccharomyces cerevisiae, Drosophila melanogaster
and homo sapiens. One hypothetical protein called W02B12.9 was
revealed, which shows similarity to members of mitochondrial
solute carrier family. It localizes to the reverse strand of
chromosome 2, has four exons, and is predicted to have 321
amino acids and a molecular weight of 34.1 kD (Figure 1A). The
amino acid sequence identities between W02B12.9 and its
counterparts of human, drosophila or yeast species are more than
40% (Figure 1B). The predicted transmembrane regions of
mitoferrin from these species were obtained and the alignment
of these regions also suggests that they are conserved in evolution
(Figure 1B). W02B12.9 should be worm mitoferrin and there are
several evidences: Firstly, mitoferrin proteins are physiologically
important. As multicellular organism worms should have its
mitoferrin and W02B12.9 is the most likely candidate because of
its high amino acid sequence identity to mitoferrin from other
species. Secondly, the existence of W02B12.9 mRNA was
confirmed (wormbase), and was also shown by our reverse
transcription PCR experiments. Thirdly, the transcriptional green
fluorescent protein (GFP) fusion reporter suggested that W02B12.9
was expressed from embryo to adult in many tissues including
intestine and neurons [41]. Finally, proteins involved in iron
homostasis regulation and iron-sulfur cluster biogenesis are usually
conserved in evolution [1]. Based on these evidences, it is very
likely that W02B12.9 is the worm mitoferrin and we call it mfn-1 for
convenience according to the nomenclature of C. elegans. (http://
www.cbs.umn.edu/CGC/nomenclature/).
RNAi treatment of mfn-1 leads to slow locomotion and
small body size
RNAi technology is frequently used in C. elegans for rapid study
of gene functions in vivo. It can be performed by feeding worms
with bacteria expressing dsRNA, by injecting dsRNA into gonad,
by soaking worms in dsRNA solution or by making transgene
animals expressing dsRNA in vivo. Of these methods, feeding
RNAi is the most common used because of its simplicity [38]. We
found that worms feeding on E.coli HT115(DE3) strain containing
the mfn-1 RNAi construct had slowed movements. We transferred
five to seven one-day old hermaphrodites onto NGM plates
without food (worms often move regularly in the absence of food)
and counted their body bends in 20 seconds. The results showed
that body bends rate was decreased by about 35% by RNA
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activity was maintained for a longer time, which declined slowly
and finally overshadowed that of control at old age (our
observations). Mfn-1 RNAi worms had small but well proportioned
body size, and appear thin and pale (Figure 2B). Body length was
measured every 24 hours during worms’ growth and the results
showed that growth rate was decreased by mfn-1 RNAi treatment,
but the growth period was neither prolonged nor shortened
(Figure 2C).
Small body size was often associated with increased longevity.
For example, worm strain with mutation in eat-2 gene, which
mimics dietary restriction (DR), have small body size as well as
increased lifespan [42]. And mitochondrial dysfunctions caused by
mutations in genes such as clk-1, isp-1, and sod-2, lead to increased
longevity and slowed growth [43,44].
However, small body size was not prerequisite for lifespan
extension, and it can be uncoupled from longevity some times as
was reported [45]. Further studies are needed to reveal whether
Figure 1. Predicted W02B12.9 gene structure and the amino acid sequences alignment of mitoferrin proteins from species. A)
Predicted gene structure of W02B12.9. Black box, exon; white box, untranslated region; line between boxes, intron. B) Alignments of the amino acid
sequence of W02B12.9 with human mitoferrin 1 (mfrn1) and mitoferrin 2 (mfrn2), yeast Mrs3 and Mrs4, and Drosophila dmfrn. Identity (black boxes)
and similarity (grey boxes) in the six sequences are highlighted and bars above the sequences indicate predicted transmembrane helices H1–H6.
GeneBank accession numbers: W02B12.9 NP_496447.1; mitoferrin 1 NP_057696.2; mitoferrin 2 NP_112489.3; Mrs3 NP_012402.1; Mrs4 NP_012978.1;
dmfrn NP_651600.1.
doi:10.1371/journal.pone.0029666.g001
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RNAi worms.
Mfn-1 RNAi results in reduced brood size and abnormal
gonad morphology
It was reported that mitoferrin is essential for male fertility of
Drosophila melanogaster [25]. We also found that mfn-1 RNAi
worms produced fewer progenies each day than control
(Figure 3A), and the total progenies produced were significantly
decreased too (Figure 3B). In order to investigate the cause of the
reduced brood size, we examined age matched adults under
microscope. Images were obtained using a Nikon Eclipse E600
microscope equipped with a Nikon digital camera. Two-day old
mfn-1 RNAi treated hermaphrodites were found to have fewer
matured oocytes than control at the proximal side of the gonad
arm (Figure 3C). In l4440 RNAi worms the oocytes are tightly
arranged and exhibited regular structures, while in mfn-1 RNAi
worms they are loosely arranged and often showed abnormal
structures (Figure 3C). Although brood size was affected by RNA
interference of mfn-1, the reproductive period was not influ-
enced. We found that worms began or stopped laying eggs on
the same day as did control. Previous studies showed that germ
line deficiency can result in extended lifespan [46]. It is therefore
interesting to investigate in future studies whether germ line
plays some roles or not in lifespan modulation of mfn-1 RNAi
worms.
The number of mitochondria increased six fold during
transition from L4 to adult, perhaps due to increased demand
for energy during germ line development [47]. And during the
reproductive period, worms lay hundreds of eggs in the first two
days (Figure 3A). Therefore, the amount of iron may be
insufficient to meet the needs of germ line development and
offspring production, which may contribute to the reduced brood
size of mfn-1 RNAi worms.
Mfn-1 RNAi worms exhibit significantly extended lifespan
and increased sensitivity to paraquat
Gene mutations affecting mitochondria function can sometimes
increase longevity in C. elegans as reported [47–49]. In accordance
with previously studies, we found that lifespan was significantly
extended by down-regulation of mfn-1, a predicted mitochondrial
inner membrane protein (Figure 4A). We performed the tests
many times and observed an increase in longevity by 50% to 80%
in N2 strain, the representative results were shown in Table 1 and
Figure S1.
Although RNAi technology is an important reverse genetic
approach to the study of gene functions in C. elegans, it could not
completely inhibit gene expression and the inter-experiments
variations are often large [49,50]. For example, daf-2 mutant
doubles lifespan while daf-2 RNAi only increased lifespan by less
than 30% as reported [49]. Besides, some tissues like neurons are
refractory to RNAi. Nevertheless, we observed consistent and
Figure 2. Mfn-1 RNAi treated worms have decreased locomotive activity and small body size. A) Average body bends per 20 s of mfn-1
RNAi individuals are 1461, and that of l4440 RNAi animals are 2261, p,0.0001. The histogram represents average 6 SD of three independent
experiments with five animals for each measurement. B) Representative photographs of 2-day old adults feeding on l4440 RNAi and mfn-1 RNAi
vectors. Scale bars=100 mm. C) Measurement of body length every 24 hours during growth. The final body length is 1.0160.16 mm of mfn-1 RNAi
worms, and that of control is 1.3360.04 mm, p,0.0001. The histogram represents average 6 SD of five independent experiments with more than 30
animals measured respectively each day.
doi:10.1371/journal.pone.0029666.g002
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using the RNAi hypersensitive strain eri-2, whose neurons are also
sensitive to RNAi, more than doubled lifespan was uncovered by
mfn-1 RNAi treatment (Figure 4A and Table 1). Therefore, down-
regulation of mfn-1, at least to some extent, can extend lifespan
significantly in C. elegans.
In order to investigate whether the extended life span was
resulted from increased protection from oxidative stress or not, we
studied how mfn-1 RNAi affects survival by treating worms with
paraquat, which produces superoxide radicals through a radical
ion intermediate and was widely used to assess sensitivity to
oxidative stress. We monitored worms’ survival in paraquat
solution every five hours and found that mfn-1 RNAi worms were
more sensitive to paraquat at multiple time points throughout the
experiments (Figure 4B). More detailed results were shown in
Figure S2. Therefore, animals have decreased protection from
oxidative stress, at least shown by this paraquat sensitivity test.
This is somewhat inconsistent with the oxidative stress theory of
aging, which states that organisms age because cells accumulate
free radical damages over time. However, this theory is
confronting with growing challenges [51–55]. For example, worm
strains with mutations in sod genes have extended lifespan and
show increased sensitivity to oxidative stress [44]. Low concen-
tration of paraquat or mild heat shock treatment can extend
lifespan and at the same time increase ROS levels in C. elegans [56–
58]. Furthermore, adding antioxidants such as N-acetyl-cysteine or
vitamin C can block lifespan extension in some long-lived mutants
[56].
Further study is needed to reveal the pathways or factors
responsible for these phenotypes, which may contribute to our
understanding of aging and perhaps have implications in
treatment of diseases with mitochondrial iron accumulation.
Finally, reduction of mfn-1 mRNA levels by RNA interference
was confirmed by qRT-PCR (Figure 5). To further address the
issue that these results might be caused by off-targeting effects,
Figure 3. Mfn-1 RNAi results in reduced brood size and
abnormal gonad morphology. A) Progeny number was measured
every day after L4 stage. The results represent five independent
experiments with totally 30 worms measured respectively each day. The
histogram represents average 6 SD. B) Total brood size measured.
Average brood size of l4440 RNAi worms is 290620, while the brood
size of mfn-1 RNAi worms is 144651, p,0.0001. Thirty brood sizes were
measures respectively. C) Gonad images of 2-day old adults. Arrow
indicates oocyte, scale bar=30 mm.
doi:10.1371/journal.pone.0029666.g003
Figure 4. Mfn-1 RNAi worms show extended lifespan despite
their hypersensitivity to paraquat solution. A) Lifespan measure-
ment of worms. Lifespan was measured as described in Materials and
Methods. Proportion of surviving animals is plotted against days of
adult life. Average lifespan of N2 wild type worms treated by mfn-1 and
control RNAi are 24.5 and 16.6 days respectively, and that of eri-1 strain
are 29.1 and 14.1 days respectively. The date indicates that lifespan is
significantly increased by RNA interference of mfn-1 in both N2 and eri-1
strains, p,0.0001. B) Paraquat sensitivity assay. Three-day old adults
were used for the test and paraquat concentration was 100 mM. Mfn-1
RNAi worms are more sensitive to paraquat mediated oxidative stress.
P,0.0001, P value represents log rank test for the experiment,
comparing survival time of the l4440 RNAi and mfn-1 RNAi worms.
The figure shows results of one representative experiment. More results
are shown in Figure S2.
doi:10.1371/journal.pone.0029666.g004
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constructed. Similar phenotypes such as small brood size, small
body size and increased longevity were observed by RNAi
treatment using this vector, thus the off-targeting effects was
excluded (Figure S3).
Discussion
Mitochondrial iron homeostasis is essential for cell functions,
such as heme and iron-sulfur cluster biogenesis. Little was known
about the mechanisms regulating mitochondrial iron homostasis.
Iron transport into mitochondria is facilitated by mitoferrin 1/2
which belong to the mitochondrial solute carrier family. As the
gate controlling iron input, mitoferrin 1/2 must play important
roles in iron regulation. Using C. elegans as model, we found that
animals displayed phenotypes of small body size, reduced
fecundity, slow locomotion and increased sensitivity to paraquat
by mfn-1 RNAi treatment. Surprisingly, lifespan was significantly
extended. These results indicate that mitoferrin is essential for
modulation of growth, reproduction, locomotion and longevity.
Some of the phenotypes we observed such as reduced brood size,
slow growth and embryonic lethality have been reported by some
large-scale genome RNAi screens [50,59,60].
There are also several large-scale genome RNAi screens for
longevity genes in C. elegans [47,49,61]. More than one hundred
genes are uncovered that can increase lifespan by 10% to 90%
when down-regulated. These genes are involved in a diversity of
biochemical processes such as protein turnover, reproduction,
energy metabolism, signaling, gene expression, and molecular
transport. Those screens cover more than 80% of all 19000 C.
elegans open reading frames at the most. Thus, not all genes are
screened for longevity.
The efficiency of RNAi in suppressing gene expression could be
variable between experiments and it is also possible that if two
genes have identical or near identical sequences, both of them
could be down-regulated by RNAi. Besides, cross-contamination
also exists sometimes. There are false-positive and false-negative
results in these screens. Particularly, false-negative rates are usually
more than 50%, and in the study of postembryonic phenotypes the
rate can surpass 80% as reported [50]. Some well known longevity
genes were not revealed by these screens. Because of these reasons,
it is not a surprise that W02B12.9 (mfn-1) was not revealed by these
longevity screens. To further confirm the lifespan extension
observed in mfn-1 RNAi worms, we used the RNAi hypersensitive
strain eri-1, of which neurons are also sensitive to RNAi. The result
showed that lifespan was more than doubled in this strain by mfn-1
RNAi treatment. To address the possibility that the result might be
caused by off-targeting effects, we constructed another vector
targeting a different region of mfn-1 and similar phenotypes
including lifespan extension were observed by using the new
vector. Therefore, the result was not caused by off-targeting
effects.
The phenotypes such as small body size, reduced fecundity, and
slowed locomotion were found to be associated with many
longevity mutants, such as clk-1, nuo-2, and isp-1 which affect
mitochondria function, and with eat-2 mutant that mimics dietary
restriction.
Although mfn-1 RNAi worms were smaller and produced fewer
progenies than control, their growth and reproduction periods
seem normal, neither prolonged nor shortened. It was reported
that the decreased body size and brood size can be uncoupled
from longevity in some cases and are not prerequisite for lifespan
extension [62]. Further studies are needed to reveal whether there
are any correlations between lifespan and body size or brood size
in mfn-1 RNAi worms.
Previous studies showed that mitochondria dysfunction could
activate some unknown compensation pathways and led to
increased lifespan as a result [63]. This might be one of the
reasons why lifespan was extended in mfn-1 RNAi worms.
However, different mutants that cause mitochondrial dysfunction
may activate different compensation pathways. For instance, some
longevity mutants depend on daf-16 to increase lifespan, while
most others don’t [48]. Furthermore, some mutants affecting
mitochondria function lead to decreased lifespan, such as mev-1
and gas-1 [63]. This suggests the complexity of mitochondria
dysfunction mediated pathways in the modulation of lifespan.
During the development and reproductive period worm grows
rapidly and lays hundreds of eggs per day. A large amount of iron
Table 1. Summary of the results of lifespan assays.
Experiment Number RNAi Treatment Maximum Lifespan Median Lifespan Mean Lifespan P N
1 l4440 26 16 16.6 60
mfn-1 39 24 24.5 ,0.0001 60
2 l4440 26 16 17.0 55
mfn-1 46 28 27.4 ,0.0001 55
3 l4440 27 16 16.2 60
mfn-1 42 27 26.6 ,0.0001 60
Data are combined from three independent experiments and lifespan was measured at 20uC. P values were obtained from Log-rank tests.
doi:10.1371/journal.pone.0029666.t001
Figure 5. Reduction of mfn-1 mRNA levels is confirmed by qRT-
PCR. The decrease of mRNA level after RNAi treatment is assessed by
qRT-PCR. The data shows that mfn-1 mRNA level in animals treated by
mfn-1 RNAi is less than 30% the level of control worms, p,0.0001.
Histogram represents normalized mRNA levels and error bar indicates
standard deviation of three independent experiments.
doi:10.1371/journal.pone.0029666.g005
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quantity may be insufficient if mfn-1 protein was down-regulated
by RNAi. This might explain why mfn-1 RNAi worms have
phenotypes such as small body size, reduced fecundity, and slowed
locomotion. When the rapid growth and reproduction ceased, less
iron should be sufficient to maintain normal functions. If the
amount of iron imported exceeds the ability of mitochondria can
use, it may deposit in mitochondria and interfere with normal
functions. This hypothesis was supported by the fact that iron was
accumulated in tissues of aged animals. Therefore, mfn-1 RNAi
treatment might contribute to lifespan extension by preventing
aging associated mitochondrial iron accumulation.
Iron homeostasis disruption is associated with many genetic
diseases, such as Fiedreich’s ataxia, Alzheimer’s Disease (AD),
Parkinson’s disease (PD) and Multiple Sclerosis (MS). It was
reported that mitoferrin was up-regulated in yeast and mouse
models of Fiedreich’s ataxia [29], which suggests its involvement in
the pathogenesis of diseases with mitochondrial iron accumulation.
Down-regulating the expression of mitoferrin or partially blocking
the iron import channel by drugs or other approaches in the future
should alleviate the symptoms of patients by preventing iron
accumulation. In addition, iron chelators are being used for
treatment of mitochondrial iron accumulation related diseases and
are demonstrated can alleviate patients’ symptoms [64–66].
In the studies we found that mfn-1 RNAi worms were more
sensitive to paraquat, indicating decreased protection from
oxidative stress. This is somewhat inconsistent with the oxidative
stress theory of aging, which states that organisms age because cells
accumulate free radical damages over time. However, this theory
is confronting with growing challenges which suggests the
complicated relationship between ROS and aging.
We believe that further investigation into the pathways or
factors responsible for the extended lifespan and other phenotypes
should contribute to our understanding of aging and may also
have implications in the treatment of mitochondrial iron disorder
related diseases.
Supporting Information
Figure S1 Lifespan of mfn-1 RNAi and l4440 RNAi
treated worms. A, B and C represent three independent
experiments and the results show that lifespan was markedly
extended by mfn-1 RNAi treatment at 20uC. Lifespan was
measured as described in Materials and Methods. Proportion of
surviving animals is plotted against days of adult life. P,0.0001 in
all the three measurements, values of P are obtained from log rank
test. The data from all the three independent experiments are
summarized in Table 1.
(TIF)
Figure S2 Paraquat sensitivity tests of mfn-1 RNAi and
l4440 RNAi worms. A, B and C represent three independent
experiments. Three-day old worms were used for the test and
paraquat concentration was 100 mM. P,0.001, P values
represent log rank test for each of the experiments, comparing
survival time of the l4440 RNAi and mfn-1 RNAi animals.
(TIF)
Figure S3 Phenotypes of worms feeding on RNAi vector
targeting a different region of mfn-1. A) Body size was
decreased by mfn-1 RNAi treatment using this vector. Average
body length is 1.0360.04 mm of mfn-1 RNAi worms, and that of
control is 1.3060.01 mm, p,0.0001. The histogram represents
average 6 SD of three independent experiments with 30 animals
measured respectively. B) Total brood size measured. Average
brood size of l4440 RNAi worms was 293613, and the brood size
of mfn-1 RNAi worms was 132636, p,0.0001. Ten brood sizes
were measured respectively. C) Lifespan measurement of worms.
Average lifespan of N2 wild type worms treated by mfn-1 and
control RNAi were 23.2 and 16.1 days respectively, p,0.0001,
n=60. The experiments were repeated three times.
(TIF)
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